Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nanoparticles for cancer therapy
KTH, School of Electrical Engineering (EES), Micro and Nanosystems.
2017 (English)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 114, no 27-29Article in journal (Refereed) Published
Abstract [en]

Nanoparticles carry a big promise in oncology, for diagnosis/imaging, therapy, or both (theragnostics). As common in medical history, there is a huge gap between the exciting experimental possibilities and data and clinical studies making use of it. Of the cell-containing nanoparticles, only one formulation using gene-directed enzyme prodrug therapy (GDEPT) with CYP2B1 and ifosfamide was used in early clinical studies. Of the cellfree nanoparticles, some drug-releasing (doxorubicin) ones are in clinical use for trans-arterial chemoembolization (TACE) in liver tumors and metastasis. Using liposomes, both paclitaxel and irinotecan have been used in pancreatic cancer as the model indication. Nanoparticle-albumin-bound paclitaxel (NAB-paclitaxel) has also been developed and is now registered as a drug for first-line therapy of pancreatic cancer, as is the liposomal irinotecan. The novel nanoparticle formulations carry a big promise for even better performance, both in diagnosis and therapy; however, few of these has entered the clinic as of today.

Place, publisher, year, edition, pages
Swedish Medical Association , 2017. Vol. 114, no 27-29
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:kth:diva-216757Scopus ID: 2-s2.0-85021917779OAI: oai:DiVA.org:kth-216757DiVA: diva2:1151689
Note

QC 20171024

Available from: 2017-10-24 Created: 2017-10-24 Last updated: 2018-01-13Bibliographically approved

Open Access in DiVA

No full text

Scopus

Search in DiVA

By author/editor
van der Wijngaart, Wouter
By organisation
Micro and Nanosystems
In the same journal
Läkartidningen
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 47 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf